Looking for a buyer.
The Company is in search of an opportunity to sell to an organization that has the ability to fully commercialize its revolutionary FDA Cleared and CE Marked and patented, single use needle biopsy closure device. The device efficiently seals biopsy channels, enhancing safety for high-risk patients and enabling the use of larger needles for more substantial tissue samples in fewer passes. Its usage may reduce procedure costs by eliminating the need for certain medications, hemostatic agents, and post-procedure observation. Effective channel sealing may also minimize hemorrhage, leading to improved patient outcomes. The device stands out as the only patented electro-cautery device designed to fit biopsy channels, ensuring innovation and effectiveness. NDA is required to secure comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Detailed Information Facilities: Relocatable worldwide. Competition: In CIM, NDA required. Growth & Expansion: Significant growth opportunity. Financing: TBD if structure and terms are acceptable. Support & Training: As needed. Reason for Selling: The Owner wishes to capitalize on the significant IP and momentum gained by the company thus far.

listing type
exclusive representation
industry
Healthcare
location
Los Angeles, CA, USA
revenue
$11,079
ebitda
$2,673
To download teaser or contact poster, please sign in.